Best of ASCO® Montreal 2024

Wednesday, July 10, 2024

Event Type: In-Person
Conference Venue: Montreal Marriott Chateau Champlain
1050 Rue De la Gauchetière O, Montréal, QC H3B 4C9
Directions: Google Maps link

Best of ASCO - Montreal

Event Landscape

OncologyEducation’s Best of ASCO® Montreal 2024 Conference is licensed by the American Society of Clinical Oncology® and will be an all-day event on July 10, 2024.

Chaired by Dr. Kim Ma and Dr. Jamil Asselah, the Best of ASCO® Montreal Conference provides oncologists and medical professionals with an expert summary of the most significant research advances, groundbreaking insights, and clinically relevant abstracts presented at the 2024 ASCO® Annual Meeting.

With expert-led sessions focused on multiple cancer types, you’ll learn the latest therapy approaches to enhance your clinical practice and improve patient outcomes.

The Best of ASCO® 2024 Montreal faculty will draw from some of Quebec’s most influential oncologists.

Icon Chair Speaker


Type here

Learning Objectives

  1. Summarize the most significant treatment advances presented at the 2024 ASCO® Annual Meeting.
  2. Describe the current standard of care for key malignancies.
  3. Discuss the current controversies in the management of specific cancers.

Scientific Agenda

Click below to learn more about the scheduled presentations and incredible speaker lineup at the Best of ASCO® Montreal Conference 2024.

Meet the Best of ASCO® Montreal 2024 Conference Co-Chairs

Dr. Kim Ma

Dr. Kim Ma
Medical Oncologist McGill University

Dr. Ma is an assistant professor at McGill University, and hematologist-oncologist at the Jewish General Hospital, Montreal, Canada. Her current fields of interest are hereditary GI cancers, as well as system optimization. She is investigator in phase 1 to 3 clinical trials with a focus in GI, breast and gynecological cancers.

Dr. Jamil Asselah

Dr. Jamil Asselah
Medical Oncologist McGill University

Trained in Algiers and Paris as a medical oncologist, Dr. Asselah completed a 2-year fellowship on phase 1 clinical trials at the Investigation Unit of the Curie Institute Cancer Center in Paris, France.
In 2008, he joined the Université de Sherbrooke as an Assistant Professor, developing new research protocols in breast cancer and standardizing treatment practices at the Centre Hospitalier Universitaire de Sherbrooke, where he also launched theoncology residency program.
Dr. Asselah joined McGill in 2011 as an Assistant Professor in the Department of Oncology, and is now Associate Professor. He is on staff as a medical oncologist at the McGill University Health Centre, where he spearheaded a working group standardizing treatment guidelines for breast cancer. He was the first Site Lead for the Rossy Cancer Network. Dr. Asselah has been the principal investigator in numerous clinical research protocols and has been part of several research groups at the provincial and national levels. His research interests include breast cancers, gastrointestinal cancers, and cancers of the head and neck. Dr. Asselah is also a leader of the “Opal” team and has been involved in the development and implementation of “Opal,” an innovative patient portal that provides patients with immediate access to their personal health information.
More recently with the spread of the COVID-19 pandemic in Québec, Dr. Asselah has assumed a leadership role through his work with the Ministère de la Santé et des Services sociaux (MSSS), helping to coordinate efforts to mitigate risks to cancer patients despite the constraints imposed by the current situation.

Registration for Healthcare professionals can be completed above. Industry representatives (both sponsor and non-sponsor) must contact Kelly Allan at [email protected] for registration and sponsorship opportunities. Industry registrations will not be accepted through the website.


​For sponsorship-related inquiries, please contact Bernadette Gregoris at [email protected].

Best of ASCO® Montreal 2024 Sponsors

Platinum sponsors


Gold sponsors

Ipsen logo

Silver sponsor

All sales are final, refunds will not be accepted.

Please note mdBriefCase Group Inc. O/A Oncology Education cannot provide visa support for event attendees, including letters of invitation. Event attendees are solely responsible for obtaining any necessary documentation required for travel and participation in the event. No refunds shall be provided to individuals who are unable to attend.

Register Now